Cargando…
Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
BACKGROUND AND OBJECTIVE: Chronic insomnia has major consequences for daytime functioning, yet no fully validated patient-reported outcome instrument for once-daily assessments is available to measure these consequences. This study describes the development and psychometric evaluation of the Insomni...
Autores principales: | Hudgens, Stacie, Phillips-Beyer, Andrea, Newton, Louise, Seboek Kinter, Dalma, Benes, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884372/ https://www.ncbi.nlm.nih.gov/pubmed/33131027 http://dx.doi.org/10.1007/s40271-020-00474-z |
Ejemplares similares
-
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
por: Hudgens, Stacie, et al.
Publicado: (2023) -
Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant
por: Phillips-Beyer, Andrea, et al.
Publicado: (2023) -
Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials
por: Heidenreich, Sebastian, et al.
Publicado: (2022) -
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
por: Kunz, Dieter, et al.
Publicado: (2022) -
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
por: Di Marco, Tobias, et al.
Publicado: (2023)